Matt S Lallas, MD

 
Dr. Matt Lallas is a pediatric neurologist with the Nicklaus Children’s Hospital Neuroscience Institute. He earned his medical degree from the Rosalind Franklin University of Medicine and Science in North Chicago, Illinois. Dr. Lallas completed two years of pediatric residency training at Children’s Hospital Los Angeles in California, followed by a residency in pediatric neurology at the same institution. He then pursued a fellowship in clinical neurophysiology at Nicklaus Children’s Hospital. His interests encompass clinical epilepsy, including the care of patients with medically resistant epilepsy with treatment through surgical, neuromodulatory, or dietary methods; analysis of electroencephalography data for three-dimensional representation and correlation to imaging; as well as complex epilepsy related to genetic conditions, including channelopathies and tuberous sclerosis. 
 
Dr. Lallas has three board certifications through the American Board of Psychiatry and Neurology and is certified in neurology with special qualification in child neurology, clinical neurophysiology and epilepsy. He is a member of the American Academy of Neurology, American Clinical Neurophysiology Society and American Epilepsy Society. His work has been published in peer-reviewed journals and he has presented at medical conferences. 
 
Dr. Lallas is employed by Nicklaus Children’s Pediatric Specialists (NCPS), the physician-led multispecialty medical group practice of Nicklaus Children’s Health System. 
 
Founded in 2001, Nicklaus Children’s Hospital’s Neuroscience Institute is one of the largest comprehensive pediatric programs dedicated solely to the care of the developing brain. It brings together world-renowned specialists in numerous pediatric neuroscience subspecialties with cumulative clinical experience unparalleled in the United States. Since 2008, the program has been ranked among the nation’s top-tier programs for pediatric neurology and neurosurgery by U.S. News & World Report. The clinical and research leadership of the program serves as a beacon to families confronting the uncertainty of a child with a brain disorder, offering the latest treatments and assessment techniques, many of which were developed by the Neuroscience Institute team.